Provexis PLC (PXS)
Industry Drug Manufacturers - Specialty & Generic
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
0.505p
Buy
0.55p
-0.0425p (-7.46%)
Prices updated at 23 May 2025, 16:34 BST
| Prices minimum 15 mins delay
Prices in GBX
Provexis PLC is engaged in developing and licensing the proprietary Fruitflow, which is a heart-health functional food ingredient for the functional food sector.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
In the news
Sharecast service unavailable
Press releases
07 Jan 202531 Dec 202431 Dec 202418 Dec 202425 Oct 202430 Sep 202430 Apr 202428 Mar 202429 Dec 202326 Oct 2023
Key dates
| Forecast date | |
|---|---|
| Half yearly results | Dec 2025 |
| Annual general meeting | Oct 2025 |
| Final results | Sep 2025 |
| Annual report | Sep 2025 |
| Previous date | |
|---|---|
| Half yearly results | Dec 2024 |
| Annual general meeting | Oct 2024 |
| Final results | Sep 2024 |
| Annual report | Sep 2024 |
Company reports
31 Mar 2023
Annual Report 30 Sep 2023
Quarterly Report 